Technical Articles

TP53 drug discovery
P53 突变：从守护者到失守，如何改写肿瘤治疗叙事？
P53 in Biopharma: From a 40-Year Drug Hunt to Reagent Standardization
发布时间 2026-10-10
Why P53 has driven four decades of drug discovery yet remains unsolved, and how standardized recombinant P53 reagents support target validation, screening and mechanistic studies across the industry.
View details
  • Cancer
  • P53
  • TP53 drug discovery
  • targeted therapy
  • PROTAC
  • reagent standardization
  • UA085067
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsCalculator ToolsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UNIV Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 苏ICP备2025207586号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.